| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |